When do you reckon we will see this happen again with the company but with beckman instead
The Company today advises that the discussions with BD have not been successfully concluded and the supply and distribution agreement originally entered into in August 2012 has been terminated. The previous guidance for the results for the year ended 30 June 2013 of revenues of £5.4m (2012: £5.6m) and a loss after tax of £1.2m (2012: £0.2m) remains unchanged. Development of Genedrive® has been the key focus of the Personalised Medicine division, with Preclinical Research Services and Novel Therapies broadly in line with the prior year. Net cash as at 6 September 2013 was £6.1m. This will be reduced to £5.5m post the repayment of $1m to BD under the terms of the original agreement.
Everything number you press at the switch goes to answer Machine even folwers so what the hell is he getting paid for. Plus oh the f do they do business if they don’t answer